Shilpa Medicare Limited (SHILPAMED) reports Q4 FY26 earnings with revenue up 30% and EBITDA surging 40%.
Alembic Pharmaceuticals Limited (APLLTD) announces USFDA final approval for its Levothyroxine Sodium Tablets, expanding its generic drug portfolio.
Laxmi Dental Limited (NSE: LAXMIDENTL) announces Q4 FY26 results with 21.9% YoY revenue growth, PAT up 136.1%.
Aurobindo Pharma Limited (AUROPHARMA) announced consolidated financial results for Q4 and FY 2026, showing a 5.6% YoY revenue increase to INR 8,853 Cr.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) reports a 11.5% revenue increase and a 68.2% surge in PAT for Q4 & FY26.
Windlas Biotech Limited (WINDLAS) reports Q4 & FY26 results with 18% YoY revenue growth, Rs. 31.60 EPS, and strong net liquidity.
Max Healthcare Institute Limited (MAXHEALTH) reports a 10% YoY revenue rise to ₹2,664 Cr in Q4 FY26, with Network Operating EBITDA up 8% to ₹682 Cr.
Take Solutions Limited (NSE: TAKE) reports a strong financial performance for FY26 with ₹6,087 Lakhs consolidated total income.
Apollo Hospitals Enterprise Limited combines Apollo Cradle and Fertility with Cloudnine, forming India’s largest integrated maternity and fertility care plat.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) reports Q4 & FY26 results with highest-ever quarterly revenue and significant EBITDA margin growth.